HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account

Go back to trials list

Tissue Procurement For Hematolymphoid Conditions


RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.OBJECTIVES: Provide source of patient tissue, blood, and body fluid samples for ongoing diagnostic, prognostic, or immune-monitoring studies. Support and enhance translational, clinical and basic research for Lineberger Comprehensive Cancer Center (LCCC) members (and non-members who have an LCCC member as sponsor and collaborator) with IRB-approved studies. Maintain responsible and appropriate policies and procedures that ensure good patient care and responsible conduct of research. Address medical and legal issues, and protect participant and patient privacy and confidentiality. Provide a responsible and uniform mechanism for the integrated coordination of the hemato-pathologist and

Trial Eligibility

DISEASE CHARACTERISTICS: Diagnosis of abnormal hematopoietic/lymphoid cancer, including any of the following: Acute myeloid leukemia Acute lymphoblastic leukemia Chronic myelogenous leukemia Chronic lymphoid leukemia Non-Hodgkin lymphoma Hodgkin lymphoma Myelodysplastic syndromes Myeloproliferative disorders Multiple myeloma Waldenstrom macroglobulinemia Aplastic anemia Any other diseases that generate abnormalities in either number, function, or both of any cell type of hematolymphoid lineage Patients who are being evaluated at the hematology/oncology clinics of the University of North Carolina Hospitals, at the stem cell transplant clinic, or in the hospital PATIENT CHARACTERISTICS: Not specified PRIOR CONCURRENT THERAPY: Not specified

Study Info


UNC Lineberger Comprehensive Cancer Center

Primary Outcome

Tissue, blood, and body fluid samples collection for ongoing diagnostic, prognostic, or immune-monitoring studies

Outcome Timeframe 30 years

NCTID NCT01137643

Completion Date July 2040


Other biologic sample preservation procedure

Other cytology specimen collection procedure

Locations Recruiting

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill

United States, North Carolina, Chapel Hill

Interested in joining this trial?

Our dedicated patient navigators are here to guide you through the validation and enrollment process with ease.

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube